A client with chemotherapy-induced bone marrow suppression has received filgrastim (Neupogen) .Which laboratory finding indicates that this therapy is effective for the client?
A) Hematocrit is 28%.
B) Hematocrit is 38%.
C) Segmented neutrophil count is 2500/mm3.
D) Segmented neutrophil count is 3500/mm3.
Correct Answer:
Verified
Q2: A client receiving intravenous chemotherapy asks the
Q3: A client is receiving a chemotherapeutic agent
Q4: A client who has just had a
Q5: A client is on chemotherapy and has
Q6: A client with prostate cancer is taking
Q8: A client is receiving interleukin-2 (IL-2)for cancer.Which
Q9: A client's radiation implant has become dislodged
Q10: In evaluating dietary teaching for a client
Q11: A client is undergoing radiation therapy and
Q12: A client's spouse reports that the last
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents